A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

Clinical trial NCT07280377 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07280377
Sponsor: Oncolytics Biotech
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anal Cancer Metastatic Squamous Cell Carcinoma of the Anus Stage Unspecified Pancreatic Cancer Metastatic Unresectable Pancreatic Carcinoma

Start date: 2021-10-27
Primary completion: 2027-07-30
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.